V
Virginia Dermatology & Skin Cancer Center | Norfolk Office
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Amlitelimab
Guselkumab
Ixekizumab
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
This is a parallel group, Phase 3, multinational, multicenter, randomized, double-blind, placebo-controlled, 3-arm study for treatment of participant...
Enrolling
Dermatitis Atopic
Drug: Amlitelimab
Drug: Topical corticosteroids
This is a multinational, multicenter, randomized, double-blind, placebo-controlled, parallel, Phase 3 study for treatment of participants aged 12 yea...
Enrolling
Dermatitis Atopic
Drug: Placebo
Drug: Amlitelimab
This is an open-label, Phase 2/Phase 3, long-term extension study for treatment of participants of previous amlitelimab clinical trials in moderate t...
Enrolling
Dermatitis Atopic
Drug: Topical calcineurin inhibitors
Drug: Topical corticosteroids
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems